ACE and endothelial dysfunction: Drugs that specifically target endothelial dysfunction in these diseases may also be beneficial in CVD and some such as angiotensin-converting enzyme inhibitors, statins, and agents that target endothelial NO synthase coupling may be worth investigating as adjunct therapies in future studies.